Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders

Chris Miller-Rosales, Susan H. Busch, Ellen R. Meara, Ashleigh King, Thomas A. D’Aunno, Carrie H. Colla

Research output: Contribution to journalArticlepeer-review

Abstract

Medications for opioid use disorder (MOUD) remain highly inaccessible despite demonstrated effectiveness. We examine the extent of screening for opioid use and availability of MOUD in a national cross-section of multi-physician primary care and multispecialty practices. Drawing on an existing framework to characterize the internal and environmental context, we assess socio-technical, organizational-managerial, market-based, and state-regulation factors associated with the use of opioid screening and offering of MOUD in a practice. A total of 26.2% of practices offered MOUD, while 69.4% of practices screened for opioid use. Having advanced health information technology functionality was positively associated with both screening for opioid use and offering MOUD in a practice, while access to on-site behavioral clinicians was positively associated with offering MOUD in adjusted models. These results suggest that improving access to information and expertise may enable physician practices to respond more effectively to the nation’s ongoing opioid epidemic.

Original languageEnglish (US)
Pages (from-to)410-422
Number of pages13
JournalMedical Care Research and Review
Volume80
Issue number4
DOIs
StatePublished - Aug 2023

Keywords

  • buprenorphine
  • diffusion of innovations
  • evidence-based practices
  • opioid treatment

ASJC Scopus subject areas

  • Health Policy

Fingerprint

Dive into the research topics of 'Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders'. Together they form a unique fingerprint.

Cite this